Exor N.V. - EXXRF

EXXRF Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
EXXRF	5.4	5.4	3.3	-10.3	-9.2	-2.6	9.5	20.9	118.3	118.3
S&P 500	1.0	3.7	2.2	2.3	8.9	23.9	32.3	80.6	196.5	33856.2

Compare EXXRF with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	EXXRF
name	Exor N.V.
price	95.93
changes percentage	5.4176
change	4.93
day low	91
day high	95.93
year high	114.92
year low	88.65
market cap	20503443047
price avg 50	96.43588
price avg 200	104.25698
exchange	PNK
volume	200
avg volume	1026
open	91
previous close	None
eps	78.57
pe	1.22
earnings announcement	2025-04-08T16:18:53.000+0000
shares outstanding	213733379
timestamp	2025-01-17 20:00:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 50.3%

Overall Quarterly Financial Health: 33.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	44742000000	41844000000	6.93
gross profit	11308000000	9505000000	18.97
gross profit ratio	0.25	0.23	11.26
research and development expenses	2473000000	2088000000	18.44
operating expenses	6020000000	5398000000	11.52
interest income	0	1944000000	-100.00
interest expense	0	620000000	-100.00
ebitda	6426000000	5961000000	7.80
ebitdaratio	0.14	0.2	-28.60
operating income	5288000000	6564000000	-19.44
operating income ratio	0.12	0.16	-24.66
net income	4194000000	4227000000	-0.78
net income ratio	0.09	0.1	-7.21
eps	18.38	1.78	932.58

Overall Score of Annual Income Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 44,742 million in 2023 from 41,844 million in 2022 representing a change of 6.93%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 11,308 million in 2023 from 9,505 million in 2022 representing a change of 18.97%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 2,473 million in 2023 from 2,088 million in 2022 representing a change of 18.44%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 6,426 million in 2023 from 5,961 million in 2022 representing a change of 7.8%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Earnings per Share (EPS): EPS increased to 18.38 in 2023 from 18.38 in 2022 representing a change of 932.58%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 6,020 million in 2023 from 5,398 million in 2022 representing a change of 11.52%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to 5,288 million in 2023 from 6,564 million in 2022 representing a change of -19.44%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 4,194 million in 2023 from 4,227 million in 2022 representing a change of -0.78%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
revenue	7570000000	7570000000	0.0
gross profit	7570000000	7570000000	0.0
gross profit ratio	1	1	0.0
research and development expenses	0	0	NaN
operating expenses	10000000	10000000	0.0
interest income	0	0	NaN
interest expense	0	0	NaN
ebitda	7844500000	7844500000	0.0
ebitdaratio	1.04	1.04	0.0
operating income	7560000000	7560000000	0.0
operating income ratio	1.0	1.0	0.0
net income	7347500000	7347500000	0.0
net income ratio	0.97	0.97	0.0
eps	33.5	33.5	0.0

Overall Score of Quarterly Income Statement

0.5 out of 1

Detailed Analysis

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	94779000000	83699000000	13.24
total liabilities	61647000000	54029000000	14.10
total equity	33132000000	29670000000	11.67
cash and cash equivalents	7790000000	10631000000	-26.72
short term investments	873000000	2879000000	-69.68
long term investments	23504000000	12993000000	80.90
total current assets	49803000000	48580000000	2.52
total non current assets	44976000000	35120000000	28.06
total current liabilities	34332000000	13396000000	156.29
total non current liabilities	27315000000	40633000000	-32.78
common stock	7000000	7000000	0.00
retained earnings	0	6867488000	-100.00
total debt	39923000000	33662000000	18.60

Overall Score of Annual Balance Sheet

0.33 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 94,779 million in 2023 from 83,699 million in 2022 representing a change of 13.24%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 33,132 million in 2023 from 29,670 million in 2022 representing a change of 11.67%. This indicates an increase in shareholders' equity.

  Total Current Assets: Total Current Assets increased to 49,803 million in 2023 from 48,580 million in 2022 representing a change of 2.52%. This indicates a better liquidity position.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 61,647 million in 2023 from 54,029 million in 2022 representing a change of 14.1%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 7,790 million in 2023 from 10,631 million in 2022 representing a change of -26.72%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 873 million in 2023 from 2,879 million in 2022 representing a change of -69.68%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 34,332 million in 2023 from 13,396 million in 2022 representing a change of 156.29%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to 0 million in 2023 from 6,867 million in 2022 representing a change of -100.0%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 39,923 million in 2023 from 33,662 million in 2022 representing a change of 18.6%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
total assets	43091000000	43091000000	0.00
total liabilities	4748000000	4748000000	0.00
total equity	38343000000	38343000000	0.00
cash and cash equivalents	812000000	812000000	0.00
short term investments	0	0	NaN
long term investments	41889000000	41889000000	0.00
total current assets	821000000	821000000	0.00
total non current assets	42270000000	42270000000	0.00
total current liabilities	703000000	703000000	0.00
total non current liabilities	4045000000	4045000000	0.00
common stock	7000000	7000000	0.00
retained earnings	14695000000	14695000000	0.00
total debt	4715000000	4713000000	0.04

Overall Score of Quarterly Balance Sheet

0.0 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Debt: Total Debt increased to 4,715 million in 2024Q2 from 4,713 million in 2024Q1 representing a change of 0.04%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-2899000000	3088000000	-193.88
operating cash flow	6246000000	4918000000	27.00
free cash flow	3436000000	2470000000	39.11
capital expenditure	-2810000000	-2448000000	-14.79
depreciation and amortization	2050000000	1853000000	10.63
deferred income tax	0	-250000000	100.00
stock based compensation	17000000	7000000	142.86
accounts payables	-18998000	20862000	-191.07
inventory	0	-640000000	100.00
acquisitions net	-4027000000	-869000000	-363.41
investments in property plant and equipment	-2810000000	-2448000000	-14.79
net cash used for investing activites	-10946000000	-4099000000	-167.04
debt repayment	4938000000	509000000	870.14
common stock issued	0	0	NaN
common stock repurchased	-2115000000	-797000000	-165.37
dividends paid	-716000000	-98975000	-623.42
net cash used provided by financing activities	2107000000	2132000000	-1.17
cash at end of period	8678000000	11577000000	-25.04
accounts receivables	0	806000	-100.00
cash at beginning of period	11577000000	8489000000	36.38

Overall Score of Annual Cashflow Statement

0.56 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -2,899 million in 2023 from 3,088 million in 2022 representing a change of -193.88%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Deferred Income Tax: Deferred Income Tax increased to 0 million in 2023 from -250 million in 2022 representing a change of 100.0%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 17 million in 2023 from 7 million in 2022 representing a change of 142.86%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Dividends Paid: Dividends Paid decreased to -716 million in 2023 from -99 million in 2022 representing a change of -623.42%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 6,246 million in 2023 from 4,918 million in 2022 representing a change of 27.0%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 3,436 million in 2023 from 2,470 million in 2022 representing a change of 39.11%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -2,810 million in 2023 from -2,448 million in 2022 representing a change of -14.79%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 19 million in 2023 from 21 million in 2022 representing a change of -191.07%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to 0 million in 2023 from 1 million in 2022 representing a change of -100.0%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
operating cash flow	186500000	186500000	0.0
free cash flow	186500000	186500000	0.0
capital expenditure	0	0	NaN
depreciation and amortization	0	0	NaN
deferred income tax	0	0	NaN
stock based compensation	5050000	5050000	0.0
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	0	0	NaN
net cash used for investing activites	0	0	NaN
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	-62500000	-62500000	0.0
dividends paid	-49500000	-49500000	0.0
net cash used provided by financing activities	112000000	112000000	0.0
net change in cash	298500000	298500000	0.0
cash at end of period	298500000	298500000	0.0
cash at beginning of period	0	0	NaN

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q2 2023 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	207.17	183.63	12.82
net income per share	19.42	18.55	4.69
operating cash flow per share	28.92	21.58	34.00
free cash flow per share	15.91	10.84	46.78
cash per share	40.11	59.29	-32.34
book value per share	153.41	130.2	17.82
tangible book value per share	124.55	89.43	39.28
shareholders equity per share	41.25	90.52	-54.43
interest debt per share	184.85	150.44	22.87
market cap	19545256854.5	15563751922.3	25.58
enterprise value	51678256854.5	38594751922.3	33.90
pe ratio	4.66	3.68	26.57
price to sales ratio	0.44	0.37	17.45
pocfratio	3.13	3.16	-1.12
pfcf ratio	5.69	6.3	-9.72
pb ratio	2.19	0.75	190.75
ptb ratio	2.19	0.75	190.75
ev to sales	1.16	0.92	25.23
enterprise value over ebitda	7.01	4.59	52.92
ev to operating cash flow	8.27	7.85	5.43
ev to free cash flow	15.04	15.63	-3.74
earnings yield	0.21	0.27	-20.99
free cash flow yield	0.18	0.16	10.77
debt to equity	4.48	1.63	174.58
debt to assets	0.42	0.4	4.73
net debt to ebitda	4.36	2.74	59.34
current ratio	1.45	3.63	-59.95
interest coverage	0	10.59	-100.00
income quality	1.49	1.02	46.44
dividend yield	0.04	0.01	476.05
payout ratio	0.17	0.02	629.11
sales general and administrative to revenue	0.08	0.08	-0.68
research and ddevelopement to revenue	0.06	0.05	10.77
intangibles to total assets	0.07	0.11	-40.76
capex to operating cash flow	0.45	0.5	-9.62
capex to revenue	0.06	0.06	7.35
capex to depreciation	1.37	1.32	3.76
stock based compensation to revenue	0.0	0.0	127.13
graham number	134.26	194.37	-30.93
roic	0.06	0.08	-22.66
return on tangible assets	0.05	0.06	-16.62
graham net net	-121.76	-160.19	23.99
working capital	15530000000	35184000000	-55.86
tangible asset value	26899000000	20378000000	32.00
net current asset value	-11785000000	-5449000000	-116.28
invested capital	29403000000	52494000000	-43.99
average receivables	14856000000	9207500000	61.35
average payables	7836500000	7422500000	5.58
average inventory	8418500000	7491500000	12.37
days sales outstanding	242.39	0	NaN
days payables outstanding	85.48	88.52	-3.44
days of inventory on hand	96.12	90.65	6.03
receivables turnover	1.51	0	NaN
payables turnover	4.27	4.12	3.56
inventory turnover	3.8	4.03	-5.69
roe	0.47	0.2	129.71
capex per share	13.01	10.74	21.11

• Positive

  ROE: Return on Equity (ROE) increased to 0.47 on 2023-12-31 from 0.20 on 2022-12-31, representing a change of 129.71%. Suggesting the company has been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 4.66 on 2023-12-31 from 3.68 on 2022-12-31, representing a change of 26.57%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.45 on 2023-12-31 from 3.63 on 2022-12-31, representing a change of -59.95%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Negative

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 4.48 on 2023-12-31 from 1.63 on 2022-12-31, representing a change of 174.58%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. A ratio of 2.0 or higher is usually considered risky.

• Quarterly Financial Ratios

	2024-06-30 Q2	2024-03-31 Q1	Q/Q change %
EXXRF
calendar year	2024	2024	NaN
revenue per share	34.51	34.51	0.00
net income per share	33.5	33.5	0.00
operating cash flow per share	0.85	0.85	0.00
free cash flow per share	0.85	0.85	0.00
cash per share	3.7	3.7	0.00
book value per share	174.8	174.8	0.00
tangible book value per share	174.8	174.8	0.00
shareholders equity per share	174.8	174.8	0.00
interest debt per share	21.49	21.49	0.04
market cap	21430939437.3	22286422178.4	-3.84
enterprise value	25333939437.3	26187422178.4	-3.26
pe ratio	0.73	0.76	-3.84
price to sales ratio	2.83	2.94	-3.84
pocfratio	114.91	119.5	-3.84
pfcf ratio	114.91	119.5	-3.84
pb ratio	0.56	0.58	-3.84
ptb ratio	0.56	0.58	-3.84
ev to sales	3.35	3.46	-3.26
enterprise value over ebitda	3.23	3.34	-3.26
ev to operating cash flow	135.84	140.42	-3.26
ev to free cash flow	135.84	140.42	-3.26
earnings yield	0.34	0.33	3.99
free cash flow yield	0.01	0.01	3.99
debt to equity	0.12	0.12	0.04
debt to assets	0.11	0.11	0.04
net debt to ebitda	0.5	0.5	0.05
current ratio	1.17	1.17	0.00
interest coverage	0	0	NaN
income quality	0.03	0.03	0.00
dividend yield	0.0	0.0	3.99
payout ratio	0.01	0.01	0.00
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0	0	NaN
capex to operating cash flow	0	0	NaN
capex to revenue	0	0	NaN
capex to depreciation	0	0	NaN
stock based compensation to revenue	0.0	0.0	0.00
graham number	362.96	362.96	0.00
roic	0.18	0.18	0.00
return on tangible assets	0.17	0.17	0.00
graham net net	-17.94	-17.94	0.00
working capital	118000000	118000000	0.00
tangible asset value	38343000000	38343000000	0.00
net current asset value	-3927000000	-3927000000	0.00
invested capital	137000000	137000000	0.00
average receivables	0	15547500000	-100.00
average payables	0	3965000000	-100.00
average inventory	0	4402500000	-100.00
days sales outstanding	0	0	NaN
days payables outstanding	0	0	NaN
days of inventory on hand	0	0	NaN
receivables turnover	0	0	NaN
payables turnover	0	0	NaN
inventory turnover	0	0	NaN
roe	0.19	0.19	0.00
capex per share	0	0	NaN

• Neutral

  ROE: Return on Equity (ROE) decreased to 0.19 on 2024-06-30 Q2 from 0.19 on 2024-03-31 Q1, representing a change of 0.00%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.

  Current Ratio: Current Ratio decreased to 1.17 on 2024-06-30 Q2 from 1.17 on 2024-03-31 Q1, representing a change of 0.00%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 0.73 on 2024-06-30 Q2 from 0.76 on 2024-03-31 Q1, representing a change of -3.84%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.12 on 2024-06-30 Q2 from 0.12 on 2024-03-31 Q1, representing a change of 0.04%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 119.44 which is higher than current price 95.93, indicates the company may be undervalued.